论文部分内容阅读
目的:观察欣康注射液治疗肺心病心力衰竭的疗效。方法:肺心病心力衰竭患者110例,随机分为治疗组60例,对照组50例。治疗组在常规抗感染、平喘、强心、利尿、吸氧基础上加用欣康注射液静脉点滴,14 d为1个疗程,对照组给予常规抗感染、平喘、强心、利尿、吸氧治疗,观察肺心病患者症状改善状况。结果:常规治疗基础上加用欣康注射液静脉点滴,治疗肺心病心力衰竭效果较好。结论:肺心病心力衰竭在常规治疗基础上加用欣康注射液治疗,效果满意。
Objective: To observe the curative effect of Xinkang injection on heart failure of pulmonary heart disease. Methods: One hundred and ten patients with heart failure of pulmonary heart disease were randomly divided into treatment group (60 cases) and control group (50 cases). The treatment group was given intravenous injection of Xinkang injection on the basis of conventional anti-infective, antiasthmatic, cardiac, diuretic and oxygen inhalation for 14 days for one course of treatment. The control group was given routine anti-infective, antiasthmatic, cardiac, diuretic, Oxygen therapy, observation of patients with pulmonary heart disease to improve the situation. Results: The conventional treatment plus Xinkang injection intravenous drip, the treatment of cor pulmonale heart failure better. Conclusion: Heart failure of pulmonary heart disease is treated with Xinkang injection on the basis of routine treatment, with satisfactory results.